Neutrophilic dermatoses

J Delaleu, C Lepelletier, A Calugareanu… - La Revue de Médecine …, 2022 - Elsevier
Neutrophilic dermatoses (ND) are a group of inflammatory skin conditions characterized by
a neutrophilic infiltrate on histopathology with no evidence of infection. ND are classified …

Pyoderma gangrenosum: proposed pathogenesis and current use of biologics with an emphasis on complement C5a inhibitor IFX-1

JD Lu, M Milakovic, AG Ortega-Loayza… - Expert Opinion on …, 2020 - Taylor & Francis
Introduction Pyoderma gangrenosum (PG) is a rare neutrophilic dermatosis with no FDA-
approved treatment. The complement pathway has received renewed attention because it is …

Ti-MOF-based biosafety materials for efficient and long-life disinfection via synergistic photodynamic and photothermal effects

L Xie, H Yang, X Wu, L Wang, B Zhu, Y Tang… - Biosafety and …, 2022 - mednexus.org
Pathogenic bacterial infection is severely threatening public health globally. The multi-modal
antibacterial nanoplatforms could significantly improve the antibacterial efficiency. Here, we …

[HTML][HTML] Pyoderma gangrenosum: a retrospective study of clinical characteristics, comorbidities, response to treatment and mortality related to prednisone dose

L Schøsler, F Karsten, B Rikke - Acta Dermato-Venereologica, 2021 - ncbi.nlm.nih.gov
Pyoderma gangrenosum is an uncommon ulcerative neutrophilic dermatosis. Clinical
presentation, location and associated diseases are diverse. Treatment of pyoderma …

Pyoderma gangrenosum: a literature review

M Barbe, A Batra, S Golding… - Clinics in Podiatric …, 2021 - podiatric.theclinics.com
Pyoderma gangrenosum (PG) is a rare inflammatory skin disease that is classified as a
neutrophilic dermatosis. 1–4 It has a classic presentation of rapidly progressive, severely …

[HTML][HTML] A novel murine model of pyoderma gangrenosum reveals that inflammatory skin-gut crosstalk is mediated by IL-1β-primed neutrophils

S Jatana, AK Ponti, EE Johnson, NA Rebert… - Frontiers in …, 2023 - frontiersin.org
Pyoderma gangrenosum (PG) is a debilitating skin condition often accompanied by
inflammatory bowel disease (IBD). Strikingly,~ 40% of patients that present with PG have …

Bronchiolitis and SARS-cov-2

GP Milani, V Bollati, L Ruggiero, S Bosis… - Archives of Disease in …, 2021 - adc.bmj.com
Background It has been speculated that the SARS-CoV-2 was already widespread in
western countries before February 2020. Methods We gauged this hypothesis by analysing …

Evaluating the role of histopathology in diagnosing pyoderma gangrenosum using Delphi and PARACELSUS criteria: a multicentre, retrospective cohort study

MS Min, K Kus, N Wei, B Kassamali… - British Journal of …, 2022 - academic.oup.com
DEAR EDITOR, Pyoderma gangrenosum (PG) is a neutrophilic dermatosis that presents a
diagnostic dilemma, with nearly 20% of cases misdiagnosed. 1 Diagnostic tools, including …

[HTML][HTML] Pyoderma gangrenosum induced by secukinumab in a patient with psoriasis successfully treated with ustekinumab

AJ Petty, MJ Whitley, A Balaban, K Ellington… - JAAD case …, 2020 - Elsevier
Pyoderma gangrenosum is an inflammatory condition characterized by the presence of
painful and necrotic ulcerations with a neutrophil-rich infiltrate. Although its pathogenesis is …

The “Understanding Pyoderma Gangrenosum, Review and Assessment of Disease Effects (UPGRADE)” project: a protocol for the development of the core outcome …

J Rick, LJ Gould, AV Marzano, A Garg, D Chen… - Archives of …, 2023 - Springer
Introduction Pyoderma gangrenosum (PG) is a rare neutrophilic dermatosis that affects
approximately 0.3–6 out of every 100,000 people worldwide. Clinical trials are scarce but …